stem cells in their environment

team >

clarisse ganier

nationality

French

role

PostDoctoral Research Associate

qualifications

  • PhD, Genetics, Paris Descartes University, France, 2018
  • MSc, Genetics, Paris Diderot University, France & La Sapienza University, Roma, Italy (double degree), 2015
  • European Magistere of Genetics, 2015

 

research project titles

  • ‘Generation of a Skin Cell Atlas for the Human Cell Atlas initiative’
  • ‘Cell therapy using the therapeutic potential of different fibroblasts subpopulations’

core expertise

  • Genomics
  • Bioinformatics
  • Genetics
  • Molecular biology
  • Cell biology
  • Flow cytometry and FACS
  • Confocal and Transmission electron microscopy,
  • Time-lapse microscopy
  • Tissue engineering
  • Animal experimentation

publications

  • Wan B*, Ganier C*, Du-Harpur X, Harun N, Watt FM, Patalay R, Lynch MD. Applications and future directions for optical coherence tomography in dermatology. Br J Dermatol. 2020 Sep 24. doi: 10.1111/bjd.19553. PMID: 32974943 [PubMed]
  • Du-Harpur X*, Arthurs C*, Ganier C, Woolf R, Laftah Z, Lakhan M, Salam A, Wan B, Watt FM, Luscombe NM, Lynch MD. Clinically-relevant vulnerabilities of deep machine learning systems for skin cancer diagnosis. J Invest Dermatol. 2020 Sep 12:S0022-202X(20)32056-X. doi: 10.1016/j.jid.2020.07.034. PMID: 32931808 [PubMed]
  • Ganier C. and Gaucher S. “Emerging Technologies in Scar Management: The Role of Allogeneic Cells.” In Textbook on Scar Management: State of the Art Management and Emerging Technologies. 2020 Dec. Edited by Luc Téot, Thomas A. Mustoe, Esther Middelkoop, and Gerd G. Gauglitz, 451–55. Cham: Springer International Publishing.
  • Ganier C. and Gaucher S. “Ethical Considerations: Scar Management.” In Textbook on Scar Management: State of the Art Management and Emerging Technologies. 2020 Dec. Edited by Luc Téot, Thomas A. Mustoe, Esther Middelkoop, and Gerd G. Gauglitz, 179–81. Cham: Springer International Publishing.
  • Gaucher S., Lwin SM., Titeux M., Abdul-Wahab A., Pironon N., Izmiryan A., Miskinyte S., Ganier C., Duchatelet S., Mellerio JE., Bourrat E., McGrath JA., Hovnanian A. EB Gene trial: patient preselection outcomes for the European GENEGRAFT ex vivo phase I/II gene therapy trial for recessive dystrophic epidermolysis bullosa. Br J Dermatol. 2020 Mar;182(3):794-797 PMID: 31557321 [PubMed]
  • Izmiryan A., Ganier C., Bovolenta M., Schmitt A., Mavilio F. and Hovnanian A.   Ex vivo COL7A1 correction for Recessive Dystrophic Epidermolysis Bullosa using CRISPR/Cas9 and Homology Directed Repair. Mol Ther Nucleic Acids. 2018 Sep 7;12:554-567 PMID: 30195791 [PubMed]
  • Ganier C., Titeux M., Gaucher S., Peltzer J., Le Lorc'h M., Lataillade JJ., Ishida-Yamamoto A., and Hovnanian A. Intradermal injection of bone marrow-MSC corrects Recessive Dystrophic Epidermolysis Bullosa in a xenograft model. J Invest Dermatol. 2018 Jul 11. pii: S0022-202X(18)31965-1 PMID: 29758284 [PubMed]
  • Jacków J., Titeux M., Portier S., Charbonnier S., Ganier C., Gaucher S., and Hovnanian A. Gene-Corrected Fibroblast Therapy for Recessive Dystrophic Epidermolysis Bullosa using a Self-Inactivating COL7A1 Retroviral Vector. J. Invest. Dermatol. 2016 Jul;136(7):1346-54 PMID: 26994967 [PubMed]